Arianna Ferrari Christopher Coenen Armin Grunwald Arnold Sauter ...

Dittrich, L. (Hg.) (2007): Zootierhaltung: Tiere in menschlicher Obhut.
9. korr. Aufl., 1. Aufl. v. 1975 (Titel: Wildtiere in Menschenhand).
Verlag Harri Deutsch: Frankfurt am Main.
Dixon D. P. (2008): The blade and the claw: science, art and the creation of the
lab-monster, Social & Cultural Geography 9, 6: 671–692.
Dodman N. (1996): The dog who loved too much: Tales, Treatments and the
Psychology of Dogs. Bantam Books: New York.
Dodman N. (1998): Psychopharmacology of animal behaviour disorders.
Blackwell Publishing: Berlin.
Donner S. (2009): Aktueller Begriff: Klonierung von Nutztieren (Wissenschaftliche
Dienste, Deutscher Bundestag, «Aktueller Begriff» Nr. 105/09,
26. November 2009; unter Mitarbeit von Todic, G.); http://www.bundestag.de/
dokumente/analysen/2009/klonierung_von_nutztieren.pdf (zuletzt aufgerufen
am 23/07/10).
Donoghue J.P. (2002): Instant neural control of a movement signal,
Nature 416: 141–142.
Donoghue, J.P., 2002: Connecting Cortex to Machines: Recent Advances in
Brain Interfaces, Nature Neuroscience 5/11s: 1085–1088.
Donovan D.M. (2005): Engineering disease resistant cattle, Transgenic
Research 14(5): 563–567.
Dorn G.W., Liggett S.B. (2009): Mechanisms of pharmacogenomic effects
of genetic variation within the cardiac adrenergic network in heart failure,
Molecular Pharmacology 76(3): 466–480.
Drobne D. (2007): Nanotoxicology for safe and sustainnable nanotechnology.
Ahr Hig Rada Toksikol 58: 471–478, http://hrcak.srce.hr/file/27913
(zuletzt aufgerufen am 23/07/10).
DRV (Deutsche Reiterliche Vereinigung) (2010): Was ist Doping? Frequently
asked questions (FAQ), http://www.pferd-aktuell.de/Doc-..72697/d.htm
(zuletzt aufgerufen am 23/07/10).
Dunham R.A. (2009): Transgenic fish resistant to infectious diseases, their risk
and prevention of escape into the environment and future candidate genes for
disease transgene manipulation, Comparative immunology, microbiology and
infectious diseases 32(2):139–161.
Dupuy J.-P., Grinbaum A. (2004): Living with Uncertainty: Toward the Ongo-
ing Normative Assessment of Nanotechnology, Techné 8/2, 2004, http://www.
akademik.unsri.ac.id/download/journal/files/scholar/grinbaum.pdf
(zuletzt aufgerufen 16/08/10).
Ebert A.D., Beres A.J., Barber A.E., Svendsen C.N. (2008): Human neural
progenitor cells over-expressing IGF-1 protect dopamine neurons and restore
function in a rat model of Parkinson’s disease,
Experimental Neurology: 213–223.
Ebert A.D., Yu J., Rose F.F. et al. (2009): Induced pluripotent stem cells from
a spinal muscular atrophy patient, Nature 457: 277–280.
EFSA (European Food and Safety Authority) (2008): Food Safety,
Animal Health and Welfare and Environmental Impact of Animals derived from
Cloning by Somatic Cell Nucleus Transfer (SCNT) and their Offspring and
Products Obtained from those Animals, Published: 24 July 2008,
Adopted: 15 July 2008, http://www.efsa.europa.eu/en/scdocs/scdoc/767.htm
(zuletzt aufgerufen am 23/07/10).
EFSA (European Food and Safety Authority) (2009): Further Advice on the
Implications of Animal Cloning (SCNT), Published: 26 June 2009,
Adopted: 23 June 2009, http://www.efsa.europa.eu/en/scdocs/scdoc/319r.htm
(zuletzt aufgerufen am 23/07/10).
EGE (European Group on Ethics in Science and New Technologies) (2008):
Ethical aspects of animal cloning for food supply. Opinion no 23,
http://ec.europa.eu/european_group_ethics/activities/docs/opinion23_en.pdf
(zuletzt aufgerufen 16/08/10).
EGE (2008): Ethical aspects of animal cloning for food supply (Opinion No. 23,
16 January 2008); http://ec.europa.eu/european_group_ethics/activities/docs/
opinion23_en.pdf (zuletzt aufgerufen 16/08/10).
182 Animal Enhancement | Beiträge zur Ethik und Biotechnologie Animal Enhancement | Beiträge zur Ethik und Biotechnologie
183